<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Inherit Metab Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Inherit. Metab. Dis</journal-id>
      <journal-title-group>
        <journal-title>Journal of Inherited Metabolic Disease</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0141-8955</issn>
      <issn pub-type="epub">1573-2665</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23361305</article-id>
      <article-id pub-id-type="pmc">3825551</article-id>
      <article-id pub-id-type="publisher-id">9584</article-id>
      <article-id pub-id-type="doi">10.1007/s10545-013-9584-4</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Left ventricular noncompaction (LVNC) and low mitochondrial membrane potential are specific for Barth syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Karkucinska-Wieckowska</surname>
            <given-names>Agnieszka</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trubicka</surname>
            <given-names>Joanna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Werner</surname>
            <given-names>Bozena</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kokoszynska</surname>
            <given-names>Katarzyna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pajdowska</surname>
            <given-names>Magdalena</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pronicki</surname>
            <given-names>Maciej</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Czarnowska</surname>
            <given-names>Elzbieta</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lebiedzinska</surname>
            <given-names>Magdalena</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sykut-Cegielska</surname>
            <given-names>Jolanta</given-names>
          </name>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ziolkowska</surname>
            <given-names>Lidia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jaron</surname>
            <given-names>Weronika</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dobrzanska</surname>
            <given-names>Anna</given-names>
          </name>
          <xref ref-type="aff" rid="Aff10"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ciara</surname>
            <given-names>Elzbieta</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wieckowski</surname>
            <given-names>Mariusz R.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Pronicka</surname>
            <given-names>Ewa</given-names>
          </name>
          <address>
            <email>e.pronicka@czd.pl</email>
          </address>
          <xref ref-type="aff" rid="Aff7"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pathology, The Children&#x2019;s Memorial Health Institute, Warsaw, Poland </aff>
        <aff id="Aff2"><label/>Department of Medical Genetics, The Children&#x2019;s Memorial Health Institute, Warsaw, Poland </aff>
        <aff id="Aff3"><label/>Department of Pediatric Cardiology and General Pediatrics, Medical University of Warsaw, Warsaw, Poland </aff>
        <aff id="Aff4"><label/>Laboratory of Bioinformatics and Biostatistics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland </aff>
        <aff id="Aff5"><label/>Department of Biochemistry and Experimental Medicine, Children&#x2019;s Memorial Health Institute, Warsaw, Poland </aff>
        <aff id="Aff6"><label/>Nencki Institute of Experimental Biology, Warsaw, Poland </aff>
        <aff id="Aff7"><label/>Department of Metabolic Diseases, The Children&#x2019;s Memorial Health Institute, Aleja Dzieci Polskich 20, 04-730 Warsaw, Poland </aff>
        <aff id="Aff8"><label/>Department of Cardiology, The Children&#x2019;s Memorial Health Institute, Warsaw, Poland </aff>
        <aff id="Aff9"><label/>Department of Surgery and Transplantation, The Children&#x2019;s Memorial Health Institute, Warsaw, Poland </aff>
        <aff id="Aff10"><label/>Department of Neonatology, Pathology and Intensive Care, The Children&#x2019;s Memorial Health Institute, Warsaw, Poland </aff>
      </contrib-group>
      <author-notes>
        <fn fn-type="com">
          <p>Communicated by: Eva Morava</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>30</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2013</year>
      </pub-date>
      <volume>36</volume>
      <issue>6</issue>
      <fpage>929</fpage>
      <lpage>937</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>7</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2013</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Barth syndrome (BTHS) is an X-linked mitochondrial defect characterised by dilated cardiomyopathy, neutropaenia and 3-methylglutaconic aciduria (3-MGCA). We report on two affected brothers with c.646G&#x2009;&gt;&#x2009;A (p.G216R) <italic>TAZ</italic> gene mutations. The pathogenicity of the mutation, as indicated by the structure-based functional analyses, was further confirmed by abnormal monolysocardiolipin/cardiolipin ratio in dry blood spots of the patients as well as the occurrence of this mutation in another reported BTHS proband. In both brothers, 2D-echocardiography revealed some features of left ventricular noncompaction (LVNC) despite marked differences in the course of the disease; the eldest child presented with isolated cardiomyopathy from late infancy, whereas the youngest showed severe lactic acidosis without 3-MGCA during the neonatal period. An examination of the patients&#x2019; fibroblast cultures revealed that extremely low mitochondrial membrane potentials (mt&#x394;&#x3A8; about 50&#xA0;% of the control value) dominated other unspecific mitochondrial changes detected (respiratory chain dysfunction, abnormal ROS production and depressed antioxidant defense). 1) Our studies confirm generalised mitochondrial dysfunction in the skeletal muscle and the fibroblasts of BTHS patients, especially a severe impairment in the mt&#x394;&#x3A8; and the inhibition of complex V activity. It can be hypothesised that impaired mt&#x394;&#x3A8; and mitochondrial ATP synthase activity may contribute to episodes of cardiac arrhythmia that occurred unexpectedly in BTHS patients. 2) Severe lactic acidosis without 3-methylglutaconic aciduria in male neonates as well as an asymptomatic mild left ventricular noncompaction may characterise the ranges of natural history of Barth syndrome.</p>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1007/s10545-013-9584-4) contains supplementary material, which is available to authorised users.</p>
        </sec>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; SSIEM and Springer Science+Business Media Dordrecht 2013</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Barth syndrome (BTHS, OMIM 302060) is one of a large group of &#x201C;mitochondrial diseases&#x201D; affecting boys (Barth et al <xref ref-type="bibr" rid="CR3">1983</xref>; Barth et al <xref ref-type="bibr" rid="CR4">2004</xref>). The disorder is a rare inborn error of metabolism. Although hundreds of cases have been identified worldwide, the Human Gene Mutation Database (HGMD) includes only 54 patients for whom a genotype has been established.</p>
      <p>BTHS is caused by mutations in the tafazzin gene (<italic>TAZ</italic>) and is inherited as an X-linked recessive trait (Barth et al <xref ref-type="bibr" rid="CR4">2004</xref>). Boys who are affected present with cardiopathy (and myopathy), neutropaenia and 3-methylglutaconic aciduria (3-MGCA) (Besley et al <xref ref-type="bibr" rid="CR5">1995</xref>; Chitayat et al <xref ref-type="bibr" rid="CR12">1992</xref>; Christodoulou et al <xref ref-type="bibr" rid="CR13">1994</xref>).</p>
      <p>The cardiac involvement in BTHS may include: left ventricular (LV) dilation, hypertrophy and noncompaction with varying degrees of congestive heart failure as well as endocardial fibroelastosis. Although most patients have dilated cardiomyopathy (DCM) the prominent LV trabeculations in half of the cases suggest a form of noncompaction cardiomyopathy (NCCM), named also a left ventricular noncompaction (LVNC), and some have hypertrophic cardiomyopathy (HCM). Cardiac transplantation may be required in some BTHS patients (Spencer et al <xref ref-type="bibr" rid="CR36">2006</xref>; Hanke et al <xref ref-type="bibr" rid="CR17">2012</xref>).</p>
      <p>BTHS is the first identified genetic defect from a rapidly expanding group of phospholipids defects (Lamari et al <xref ref-type="bibr" rid="CR27">2012</xref>), that directly affects cardiolipin (Houtkooper et al <xref ref-type="bibr" rid="CR18">2009a</xref>; <xref ref-type="bibr" rid="CR19">b</xref>). Tafazzin is a component of the mitochondrial membrane that is necessary for the proper functioning of the electron transport chain (Brandner et al <xref ref-type="bibr" rid="CR7">2005</xref>; Claypool <xref ref-type="bibr" rid="CR14">2009</xref>; Haines<xref ref-type="bibr" rid="CR15">2009</xref>).</p>
      <p>Here, we present first Polish male siblings with BTHS associated with a recurrent <italic>TAZ</italic> gene mutation and relatively mild course of the disease, in which the studies of mitochondrial function directly confirmed severe impairment in mitochondrial membrane potential (mt&#x394;&#x3A8;) and the inhibition of complex V activity.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials</title>
      <p>This investigation conforms to the principles outlined in the Declaration of Helsinki, and the study protocol was approved by The Bioethical Commission of The Children&#x2019;s Memorial Health Institute. Two patients with BTHS and seven fibroblast cultures of patients with <italic>SCO2</italic> (Pronicki et al <xref ref-type="bibr" rid="CR31">2010</xref>) and <italic>SURF1</italic> (Pronicki et al <xref ref-type="bibr" rid="CR30">2008</xref>) mutations were studied.</p>
      <sec id="Sec3">
        <title>Patient 1</title>
        <p>The boy was born at full term from a second pregnancy (there was a maternal history of a single miscarriage). His birth weight was 3.090&#xA0;g, and his Apgar score after 5&#xA0;min was a 10. During infancy, feeding difficulties, growth retardation (height 10th, weight corrected for height &lt;3rd percentile) and delayed motor development were observed (he sat at 8 mo, stood at 13 mo and started to walk at 24 mo).</p>
        <p>At the age of 14&#xA0;months, after a respiratory infection, a cardiomyopathy occurred with severe heart failure (class IV according to modified Ross Heart Failure classification). After the treatment the patient's cardiac function progressively improved. Since the age of two years no symptoms or signs of heart failure have been found. ECG was without signs of left ventricular hypertrophy. Slight cardiomegaly was observed in roentgenogram. In echocardiography the dimensions of left atrium and left ventricle diminished, the diameter of left atrium was within normal limits and the left ventricular diameter was on the upper border. The left ventricular contractility markedly improved, SF was 30&#xA0;%, EF 58&#xA0;% (modified Simpson formula), and the moderate mitral regurgitation was recorded. The ejection fraction reached about 64&#xA0;% at the age of 3.5 - 4&#xA0;years and the treatment with digoxin was stopped. In the next six following months further reduction of the left ventricular dimensions was observed and spironolacton was withdrawn.</p>
        <p>Physical development has been delayed, always with weight below the 3rd percentile.</p>
        <p>Now, at the age of 9, the patient is asymptomatic, treated only with captopril, and systematically followed by paediatric cardiologists and metabolic paediatricians.</p>
      </sec>
      <sec id="Sec4">
        <title>Patient 2</title>
        <p>The younger brother of patient 1 (no data from the fetal period is available) was healthy at birth (10 Apgar score after 5&#xA0;min, weight 3.240&#xA0;g), but he developed hypotonia, tremor and generalised oedema on the first day of life. Biochemical data showed the following: severe metabolic acidosis (pH&#x2009;7.0, HCO<sub>3</sub> 5.0&#xA0;mmol/L), markedly increased lactate in the plasma (23.1&#xA0;mmol/L) and urine, recurrent hypoglycaemia, rhabdomyolysis (CPK 7800 U/L, control below 171 U/L), liver failure and an abnormal aminoacidogram (hyperalaninaemia, hypertyrosinaemia and hypermetioninaemia). Generally the baby demonstrated &#x201C;severe neonatal lactic acidosis&#x201D;. The structure of the brain and cerebellum was normal, as determined through MRI. The ECG after birth was in normal limits. Signs of right ventricular muscle hypertrophy were described in echocardiography performed soon after birth, which completely resolved within one month.</p>
        <p>BTHS was suspected due to the positive family history, and pantothenate (a coenzyme A precursor) was administered as reported previously (Ostman-Smith et al <xref ref-type="bibr" rid="CR29">1994</xref>). Transient low serum biotinidase activity (3.68 u/mL, normal range 6-12 u/mL) were observed, and biotin was supplemented. The patient&#x2019;s clinical condition and biochemical status systematically improved, and he was discharged without treatment at the age of 6&#xA0;weeks. Recurrent skin <italic>Candida albicans</italic> infections were observed during the second year of life.</p>
        <p>The boy never had any symptoms of heart failure therefore the regular cardiological assessment was not carried out. At age 3&#xA0;years the boy is clinically asymptomatic. His weight and height are at the lower control limit (10th percentile).</p>
      </sec>
    </sec>
    <sec id="Sec5" sec-type="materials|methods">
      <title>Methods</title>
      <sec id="Sec6">
        <title>Morphological and biochemical methods</title>
        <p>Open muscle biopsy was performed at the age of 14&#xA0;days in the younger brother (patient 2) and then in the older one (patient 1) at the age of 6&#xA0;years. Histological, histochemical and spectrophotometric experiments on the muscle tissue were performed as described (Bancroft and Gamble <xref ref-type="bibr" rid="CR2">2001</xref>; Karczmarewicz et al <xref ref-type="bibr" rid="CR23">1997</xref>).</p>
        <p>The muscle ultrastructure was evaluated under a JEM-1010 electron microscope.</p>
        <sec id="Sec7">
          <title>Isolation of mitochondria from muscle biopsies</title>
          <p>Biopsy samples were stored at -80&#xA0;&#xB0;C and then defrosted and cut into small pieces prior to resuspension in homogenisation buffer. Skeletal muscles were homogenised on ice. The homogenates were centrifuged twice at 1500 x g for 5&#xA0;min. The supernatant was collected and centrifuged at 10,000 x g for 10&#xA0;min. Finally, the mitochondrial pellets were frozen at -80&#xA0;&#xB0;C until further use.</p>
        </sec>
      </sec>
      <sec id="Sec8">
        <title>Blue native PAGE and in-gel activity assays</title>
        <p>Blue native PAGE and an in-gel activity assay were performed with muscle biopsies, as described (Van Coster et al <xref ref-type="bibr" rid="CR41">2001</xref>). Briefly, the mitochondria that were isolated from the muscle biopsies were resuspended in aminocaproic acid buffer (1.5&#xA0;M 6-aminocaproic acid and 50&#xA0;mM Bis&#x2013;Tris, pH&#x2009;7.0) and supplemented with n-dodecyl-beta-D-maltoside at a final concentration of 1&#xA0;%. The samples were incubated on ice for 20&#xA0;min and then centrifuged at 20,000&#x2009;&#xD7;&#x2009;g for 15&#xA0;min. The protein concentrations of the supernatants containing the solubilised respiratory complexes were determined according to Bradford&#x2019;s method using the Bio-Rad protein estimation kit. The supernatant was supplemented with Serva Blue G (to a final concentration of 0.5&#xA0;%) and subjected to native electrophoresis on an acrylamide gel gradient of 5&#x2013;12&#xA0;% in large format. To visualise the activity of the mitochondrial ATPase (complex V), the gel was incubated at 35&#xA0;&#xB0;C in a solution containing 35&#xA0;mM Tris-HCl, 270&#xA0;mM glycine, 14&#xA0;mM MgSO<sub>4</sub>, 0.2&#xA0;% Pb(NO<sub>3</sub>)<sub>2</sub> and 8&#xA0;mM ATP (pH&#x2009;7.8). To visualise complex I activity, the gel was incubated at 35&#xA0;&#xB0;C in 3&#xA0;mM Tris&#x2013;HCl (pH&#x2009;7.4) containing 60&#xA0;&#x3BC;M NADH and 245&#xA0;&#x3BC;M nitrotetrazolium blue (NBT). To visualise complex II activity, the gel was incubated at 35&#xA0;&#xB0;C in 5&#xA0;mM phosphate buffer (pH&#x2009;7.4), 5&#xA0;mM EDTA, 10&#xA0;mM KCN, 50&#xA0;mM succinate, 0.2&#xA0;mM phenazine methosulphate and 245&#xA0;&#x3BC;M NBT. To visualise complex IV activity, the gel was incubated at 35&#xA0;&#xB0;C in 9&#xA0;ml 50&#xA0;mM phosphate buffer (pH&#x2009;7.4) supplemented with 5&#xA0;mg 3,3&#x2019;-diamidobenzidine tetrahydrochloride (DAB), 200&#xA0;&#x3BC;g catalase, 10&#xA0;mg cytochrome c and 750&#xA0;mg sucrose.</p>
      </sec>
      <sec id="Sec9">
        <title>Western blot analysis of the mitochondrial respiratory chain components</title>
        <p>The levels of the individual subunits of the mitochondrial respiratory chain were assessed using the Total OXPHOS Human WB Antibody Cocktail (MitoSciences). SDS lysates of the muscle biopsies (20&#xA0;&#x3BC;g/line) were electrophoretically separated with a 10&#xA0;% SDS-polyacrylamide gel (BioRad). The proteins were transferred onto a PVDF membrane using standard procedures. The membranes were blocked with 2&#xA0;% non-fat milk in TBS buffer containing 0.01&#xA0;% Tween 20 (Sigma Aldrich) for 1&#xA0;h. The membranes were immunoblotted with antibodies against the subunits of the individual respiratory chain complexes (1:5,000), followed by secondary HRP-conjugated antibodies (1:5,000) (Santa Cruz).</p>
      </sec>
      <sec id="Sec10">
        <title>Measurement of the mitochondrial membrane potential (mt&#x394;&#x3A8;)</title>
        <p>The mitochondrial membrane potential (mt&#x394;&#x3A8;) was measured using fluorescent indicators, as previously described (Lebiedzinska et al <xref ref-type="bibr" rid="CR28">2010</xref>; Karkucinska-Wieckowska et al <xref ref-type="bibr" rid="CR24">2011</xref>). Fibroblasts were grown in 24-well plates, washed twice with PBS and incubated with 10&#xA0;&#x3BC;M JC-1 in PBS containing 5&#xA0;mM glucose for 10&#xA0;min at 37&#xA0;&#xB0;C. The cells were then washed twice with PBS. Green and red fluorescence were measured at wavelengths of 485&#xA0;nm excitation/520&#xA0;nm emission and 535&#xA0;nm excitation/635&#xA0;nm emission, respectively, using a microplate reader (Infinite M200, Tecan, Austria).</p>
        <p>The data obtained from the Tecan microplate reader were calculated using Microsoft&#x2122; Excel 2005, and significance was assessed with Student's t-test.</p>
      </sec>
      <sec id="Sec11">
        <title>Molecular analysis</title>
        <p>Genomic DNA was extracted from Guthrie cards through incubation in the polymerase chain reaction (PCR) mixture at 95&#xA0;&#xB0;C for 50&#xA0;min. All of the exons of the <italic>TAZ</italic> gene, including the flanking introns, were amplified with PCR using seven intron-specific primer pairs. Detailed PCR protocols and primer sequence information are available upon request. Direct sequencing of the PCR products was performed using a 3130 genetic analyser (Applied Biosystems, Foster City, CA, USA). The sequences were determined on both DNA strands from at least two independent PCR products. The analysed sequence fragments were compared with the <italic>TAZ</italic> cDNA (GenBank RefSeq: NM_000116.3) and protein (GenBank RefSeq: NP_000107.1) sequences using Mutation Surveyor software version 3.30 (Softgenetics, PA). The position of the identified nucleotide change was determined based on comparison with the reference sequence, with the A of the ATG translation initiation codon designated as nucleotide +1.</p>
      </sec>
      <sec id="Sec12">
        <title>Structure-based functional analyses</title>
        <p>Sequences that were homologous to the human TAZ protein (NP_000107.1) were collected from the National Centre for Biotechnology Information (NCBI) RefSeq database. Selected sequences were aligned using the ClustalW algorithm. Globular regions were predicted using GlobPlot. Transmembrane domains were determined using TMHMM. The protein sequences were submitted to the Meta-BASIC and Protein Structure Prediction Meta-Server, which combines fold recognition and homology modelling methods. The secondary structure was determined using PsiPred. The obtained results were analysed with 3D-Jury, a consensus fold recognition method. Based on these results, the structural templates were mapped to the multiple sequence alignment of the TAZ homologs. Homology models for each of the individual domains were reconstructed using Modeller 9. The models were visualised using PyMOL and Discovery Studio Visualiser.</p>
      </sec>
    </sec>
    <sec id="Sec13" sec-type="results">
      <title>Results</title>
      <sec id="Sec14">
        <title>Molecular study</title>
        <p>The sequencing of the <italic>TAZ</italic> gene revealed a single-nucleotide mutation c.646G&#x2009;&gt;&#x2009;A leading to the missense substitution p.Gly216Arg in the hemizygous state in both brothers and in the heterozygous state in their mother (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). A pedigree analysis of the family (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) revealed the deaths of at least three male relatives (late foetal, infantile and child deaths) and at least nine potential female carriers of the <italic>TAZ</italic> mutation.<fig id="Fig1"><label>Fig. 1</label><caption><p>The DNA sequence of <italic>TAZ</italic> exon 8 with the c.646G&#x2009;&gt;&#x2009;A mutation in the proband (in the hemizygous stage), the proband&#x2019;s mother (in the heterozygous stage) and a healthy control</p></caption><graphic xlink:href="10545_2013_9584_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Pedigree of the family</p></caption><graphic xlink:href="10545_2013_9584_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec15">
        <title>Structure-based functional analyses</title>
        <p>The identified <italic>TAZ</italic> gene mutation occurs in the splice site of exon 8, which is highly conserved between species, suggesting that this variant may disrupt the function of the encoded protein (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>). A detailed analysis of the position of the mutated Gly216 showed that this residue is facing the membrane, in which the N-terminal domain of the protein is anchored (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). The Gly216 mutation segregating within this family occurs within a TAZ specific loop (position 216-232) that contains several conserved prolines that maintain specific loop flexibility.<fig id="Fig3"><label>Fig. 3</label><caption><p>The structural model of the TAZ protein rebuilt on PDB:1iuqA. The key G216 residue is indicated with a magenta stick. The dark blue element is an assumed transmembrane helix</p></caption><graphic xlink:href="10545_2013_9584_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec16">
        <title>Biochemical abnormalities</title>
        <p>Excretion of 3-MGCA in the urine was increased in all of the measurements obtained, except for the first weeks of life of the younger patient.</p>
        <p>Neutropaenia was not present at the onset. Neutrophils number fluctuated, and was normal in half of the measurements ranging from 375 to 3680 and from 230 to 2320 per mm<sup>3</sup> (control above 1500 per mm<sup>3</sup>) respectively, in the older and younger brother. In the older patient, at the age of 4&#xA0;years, an episode of severe neutropaenia was noted during the course of pneumonia.</p>
        <sec id="d30e642">
          <title>Hypocholesterolaemia and hypocarnitinaemia were not evident</title>
          <p>The level of monolysocardiolipin/cardiolipin (MLCL/CL) ratio measured at dry blood spots was increased in the older and younger brothers, respectively to 1.20 and 0.50 (normal value 0 &#x2013; 0.30). The analysis was performed in the Laboratory Genetic Metabolic Disease, Academic Medical Centre, Amsterdam.</p>
        </sec>
      </sec>
      <sec id="Sec17">
        <title>Cardiological study</title>
        <p>Multiple ECGs in patient 1 from the age of 14&#xA0;months, showed ST-T abnormalities in the form of flattening and/or biphasic T (Supplementary Fig.&#xA0;<xref rid="CR2" ref-type="bibr">3</xref>). Similar biphasic T waves without signs of chamber hypertrophy were seen in patient 2 at the age of 3&#xA0;years (Supplementary Fig.&#xA0;<xref rid="MOESM3" ref-type="media">4</xref> and <xref rid="Fig8" ref-type="supplementary-material">5</xref>).</p>
        <p>2D-echocardiography revealed some features of left ventricular noncompaction (LVNC) in both affected brothers. In patient 1 at the age of 8&#xA0;years, two-layered myocardium was seen with prominent trabeculations in the apex, with noncompacted to compacted ratio about 1.6 (Supplementary Fig.&#xA0;<xref rid="Fig9" ref-type="supplementary-material">6</xref>).</p>
        <p>In patient 2, at the age of 3&#xA0;years, two-layered myocardium was seen in systole with four trabeculations in the apical region, and the noncompacted to compacted ratio about 1.0.</p>
        <p>Holter monitoring (multiple) showed normal sinus rhythm, normal conduction intervals, without evidence of arrhythmia in all recordings in both affected brothers.</p>
      </sec>
      <sec id="Sec18">
        <title>Mitochondrial study</title>
        <p>In a study on BTHS fibroblasts, the most evident abnormality was the impairment of mitochondrial membrane potential, mt&#x394;&#x3A8;. Interestingly, the mt&#x394;&#x3A8; reduction was nearly identical in the fibroblasts of both affected brothers (40-50&#xA0;% of control), and this reduction was more extreme than the reduction observed in the fibroblasts of patients with two other mitochondrial disorders (<italic>SCO2</italic> gene or <italic>SURF1</italic> gene mutations). Control fibroblasts were included as a reference (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>The mitochondrial membrane potential in the fibroblasts of the two brothers with Barth syndrome (2 lines, <italic>n</italic>&#x2009;=&#x2009;4), control fibroblasts (4 lines, <italic>n</italic>&#x2009;=&#x2009;10), SCO2-deficient fibroblasts (3 lines, <italic>n</italic>&#x2009;=&#x2009;5) and SURF1-deficient fibroblasts (4 lines, <italic>n</italic>&#x2009;=&#x2009;6). The data shown are the mean&#x2009;&#xB1;&#x2009;SD, *<italic>p</italic>&#x2009;&lt;&#x2009;0.05 versus control</p></caption><graphic xlink:href="10545_2013_9584_Fig4_HTML" id="MO4"/></fig></p>
        <p>Other less specific changes in mitochondrial morphology and function were also observed in the studied BTHS patients. Muscle histochemistry in one of the patients revealed moderate lipid accumulation, low COX activity and a weak SDH reaction, which developed only after prolonged incubation time (1.5 and 3&#xA0;h). Relatively low activity of the respiratory chain complex IV and II&#x2009;+&#x2009;III were found by spectrophotometry of muscle homogenate. The muscle electron microscopy showed polymorphic mitochondria of variable size (0.02-0.16&#xA0;&#x3BC;m<sup>2</sup>), decreased distance between inner membrane and myelin-like structure in mitochondrial matrix, and abundant glycogen and lipid droplets in contact with the mitochondrion. The results of blue native electrophoresis and an in-gel activity assay revealed a decrease in the ATPase activity of complex V (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>). Western blot analysis (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>) revealed more complex mitochondrial dysfunction represented by lower complex V and I levels in the two studied patients versus control.<fig id="Fig5"><label>Fig. 5</label><caption><p>Blue native electrophoresis and a complex V in-gel activity assay of the mitochondria isolated from the muscle biopsies of two brothers with Barth syndrome. A significant decrease in the activity of complex V is observed compared with the control muscle biopsy. P1, older brother; P2, younger brother</p></caption><graphic xlink:href="10545_2013_9584_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>A western blot analysis shows the mitochondrial respiratory chain composition in muscle biopsies of two brothers with Barth syndrome. A decreased amount of complex V &#x3B1; subunit is observed compared with a healthy control. The 20&#xA0;kDa subunit of complex I was detectable in the older patient upon prolonged exposure. Densitometry analysis of the data is presented in Supplementary Fig.&#xA0;<xref rid="Sec2" ref-type="sec">2</xref>. P1: older brother; P2: younger brother</p></caption><graphic xlink:href="10545_2013_9584_Fig6_HTML" id="MO6"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec19" sec-type="discussion">
      <title>Discussion</title>
      <p>Although most of the known <italic>TAZ</italic> gene mutations are unique for probands and their families (Cantlay et al <xref ref-type="bibr" rid="CR9">1999</xref>; Bione et al <xref ref-type="bibr" rid="CR6">1996</xref>; Johnston et al <xref ref-type="bibr" rid="CR22">1997</xref>), the c.646G&#x2009;&gt;&#x2009;A (p.G216R) mutation detected in this family has been previously described (Kuijpers et al <xref ref-type="bibr" rid="CR26">2004</xref>). The exchange of a small amino acid for a positively charged residue (Gly216 to Arg) in a region of TAZ specific loop is likely to influence the negatively charged cardiolipins that are localised to the mitochondrial membrane, resulting in failed cardiolipin biosynthesis and reduced ATP production. The pathogenicity of the p.G216R mutation, as indicated by the structure-based functional analyses, was further confirmed by observations of an abnormal MLCL/CL ratio in the described family.</p>
      <p>The necessity of expanding the indications for differential diagnosis of BTHS for a pregnancy loss (as in the described family), and an idiopathic mitochondrial disease has been recently highlighted by Steward et al (<xref ref-type="bibr" rid="CR38">2010</xref>). Prior experience with the first two Polish BTHS patients has shown that strict compliance with the requirements of the diagnostic triad for BTHS may delay a proper diagnosis (Sweeney et al <xref ref-type="bibr" rid="CR40">2008</xref>; Werner et al <xref ref-type="bibr" rid="CR43">2011</xref>). In the younger brother who had the initial diagnosis of &#x201C;severe neonatal lactic acidosis&#x201D;, neither neutropaenia nor 3-MGCA was observed in the neonatal period, as reported (Schmidt et al <xref ref-type="bibr" rid="CR34">2004</xref>). After recovery from severe life-threatening neonatal disease, the boy did not show any cardiologic symptoms until the age of 3&#xA0;years. Except for the positive family history and the presence of the <italic>TAZ</italic> gene mutation, little laboratory evidence of BTHS existed. The symptoms of the older brother are more evident (stunted growth and cardiomyopathy) than in the younger brother but are still of only moderate intensity. Neutropaenia occurred only cyclically and was uncovered only when looked for on several occasions. The increased excretion of 3-MGCA was the most stable parameter of BTHS criteria triad in the described boys. However at neonatal period, a search for 3-MGCA in urine could be negative in affected patients. The increased excretion of 3-MGCA was not found in repeated GC-MS testing during the first three months of life of patient 2. Such phenomenon had been previously reported in one BTHS neonate (Schmidt et al <xref ref-type="bibr" rid="CR34">2004</xref>).</p>
      <p>Clinical differences in the course of BTHS have been described in the literature, even for patients that bear identical mutations. Because no phenotypic association has been found among different types of mutations and any of the clinical or laboratory abnormalities, it is likely that additional factors (acquired or inherited) modify the BTHS phenotype in individual affected patients, including members of the same family (Christodoulou et al <xref ref-type="bibr" rid="CR13">1994</xref>; Johnston et al <xref ref-type="bibr" rid="CR22">1997</xref>; Kelley et al <xref ref-type="bibr" rid="CR25">1991</xref>).</p>
      <p>Isolated LVNC is frequently described in BTHS (Brandner et al <xref ref-type="bibr" rid="CR7">2005</xref>; Chen et al <xref ref-type="bibr" rid="CR10">2002</xref>). Furthermore, Spencer et al (<xref ref-type="bibr" rid="CR36">2006</xref>) reported that many BTHS patients have qualitatively prominent trabeculations of the left ventricle, and two independent experts considered these patients to be in the left ventricular noncompaction group, even though they had not met the published criteria. Among the 30 patients with echocardiograms supporting this determination, only 16 (53&#xA0;%) demonstrated an abnormal morphology of the left ventricle with increased trabeculations.</p>
      <p>LVNC represents a wide spectrum of morphological and clinical findings. 2D-echocardiography still is the method of choice in the diagnosis of this cardiomyopathy (Engberding et al <xref ref-type="bibr" rid="CR16">2007</xref>) and characteristic echocardiographic appearance may help to differentiate LVNC from other forms of cardiomyopathy like apical hypertrophic or dilated cardiomyopathy in patients with impaired left ventricular systolic function. However the echocardiographic criteria are still controversial. The fundamental feature of the condition is the presence of the two-layered myocardium: thin compact outer layer and thick noncompact endocardial layer with increased number of trabeculations and deep intertrabecular recesses communicating with left ventricular cavity imagined by colour Doppler. It is commonly known that two-layered myocardium can be sometimes demonstrated in healthy children and adults which can lead to misleading diagnosis of LVNC. Therefore, a quantification of the noncompacted to compacted ratio was implemented, for the first time by Chin et al (<xref ref-type="bibr" rid="CR11">1990</xref>), then Ischida et al (<xref ref-type="bibr" rid="CR20">1990</xref>), Jenni et al (<xref ref-type="bibr" rid="CR21">2001</xref>) and others. There is no consensus in the literature if the ratio should be measured at end diastole or end systole neither of the cut-off value of it (1.4; 2.0; 2.3). In our centre we perform the end-systolic measurement and for children we use the cut-off value 1.4 therefore the older brother fulfills the criteria of LVNC. The younger brother with the ratio about 1.0 meets the criteria recently proposed by Stollberger et al (<xref ref-type="bibr" rid="CR39">2011</xref>). There is a broad discussion in the literature on the redefinition of the diagnostic criteria. The study of Saleeb et al (<xref ref-type="bibr" rid="CR32">2012</xref>) demonstrated that the qualitative diagnosis and quantitative measurements are poorly reproducible between observers. Transesophageal echocardiography, 3D real time and contrast echocardiography play a complementary role in patients with poor quality of transthoracic images. The usefulness of cardiac magnetic resonance, computed tomography and invasive left ventriculography was documented in the small number of patients. All the mentioned methods could be helpful in the detailed diagnosis of LVNC as well as left ventricular function assessment and further studies on this issue are necessary.</p>
      <p>In BTHS, repolarisation abnormalities predominantly include ST flattening or T-wave inversion (Ostman-Smith et al 1997; Spencer et al <xref ref-type="bibr" rid="CR36">2006</xref>). Ostman-Smith et al (<xref ref-type="bibr" rid="CR29">1994</xref>) described the development of T-wave abnormalities in the form of a &#x201C;camel&#x2019;s hump&#x201D; biphasic T-wave and progressive T-wave inversion. These abnormalities were also seen in the presented BTHS brothers.</p>
      <p>The data from the literature show that despite their currently reported good clinical condition, the boys in this study are at risk for ventricular tachycardia, which may lead to sudden cardiac death, and they require close cardiac monitoring (Barth et al <xref ref-type="bibr" rid="CR4">2004</xref>; Spencer et al <xref ref-type="bibr" rid="CR35">2005</xref>). The role of cardiolipin deficiency or altered distribution of the mitochondrial membrane phospholipids in the mechanism of arrhythmia has been considered (Spencer et al <xref ref-type="bibr" rid="CR35">2005</xref>).</p>
      <p>We previously found that the decrease in mt&#x394;&#x3A8; was less pronounced in an infant with fatal mitochondrial cardiomyopathy (Lebiedzinska et al <xref ref-type="bibr" rid="CR28">2010</xref>) and a girl with a MEGDEL association (Karkucinska-Wieckowska et al <xref ref-type="bibr" rid="CR24">2011</xref>) (70&#xA0;% and 75&#xA0;% of control, respectively). Moreover, BTHS lymphoblasts showed reduced mt&#x394;&#x3A8;, as indicated with JC-1 probe measurements (Xu et al <xref ref-type="bibr" rid="CR45">2005</xref>). Similarly, decreased mt&#x394;&#x3A8; and a lower activity of the individual respiratory chain complexes have also been reported by Besley et al (<xref ref-type="bibr" rid="CR5">1995</xref>).</p>
      <p>Tafazzin deficiency in BTHS leads to a cardiolipin remodelling defect (Houtkooper et al <xref ref-type="bibr" rid="CR18">2009a</xref>; Vrecken et al <xref ref-type="bibr" rid="CR42">2000</xref>) that affects the assembly and stability of supercomplexes of complex III and IV (and most likely also of complex V) in the inner mitochondrial membrane. These alterations result in the impairment of respiratory chain activity (Brandner et al <xref ref-type="bibr" rid="CR7">2005</xref>; Arnold et al <xref ref-type="bibr" rid="CR1">1998</xref>; Schagger and Pfeiffer <xref ref-type="bibr" rid="CR33">2000</xref>) and reduced ATP synthesis in BTHS (Haines <xref ref-type="bibr" rid="CR15">2009</xref>). Our studies show that reduced mitochondrial ATP synthase activity is accompanied by altered levels of its &#x3B1; subunit (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>). Moreover, a decrease in ATP synthase activity occurs not only with BTHS but also with other types of 3-MGCA (Besley et al <xref ref-type="bibr" rid="CR5">1995</xref>; Sperl et al <xref ref-type="bibr" rid="CR37">2006</xref>; Wortmann et al <xref ref-type="bibr" rid="CR44">2010</xref>).</p>
      <p>Interestingly, we have previously observed increased ROS production, alterations in antioxidant defence and an increased level of protein carbonylation in BTHS fibroblasts (Lebiedzinska et al <xref ref-type="bibr" rid="CR28">2010</xref>). To our knowledge, these findings have not been previously reported. Thus, one may speculate that the natural course of the disease can be influenced, for example, by a background profile of antioxidant defence capacity in an individual patient.</p>
      <sec id="Sec20">
        <title>Summary</title>
        <p>
          <list list-type="order">
            <list-item>
              <p>Our studies confirm generalised mitochondrial dysfunction in the skeletal muscle and the fibroblasts of BTHS patients, especially a severe impairment in the mitochondrial membrane potential and the inhibition of complex V activity.</p>
            </list-item>
            <list-item>
              <p>It can be hypothesised that impaired mt&#x394;&#x3A8; and mitochondrial ATP synthase activity may contribute to episodes of cardiac arrhythmia that occurred unexpectedly in BTHS patients (Brown and O&#x2019;Rourke <xref ref-type="bibr" rid="CR8">2010</xref>; Spencer et al <xref ref-type="bibr" rid="CR35">2005</xref>).</p>
            </list-item>
            <list-item>
              <p>Severe lactic acidosis without 3-methylglutaconic aciduria in male neonates as well as asymptomatic left ventricular noncompaction at ECHO record may characterise a range of natural history of Barth syndrome.</p>
            </list-item>
          </list>
        </p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Electronic supplementary materials</title>
      <sec id="SecESM1">
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="10545_2013_9584_MOESM1_ESM.doc">
            <label>Supplementary Fig. 1</label>
            <caption>
              <p>A multiple sequence alignment of TAZ proteins with the GPAT2 protein family.The sequences are labelled according to GenBank identifiers and the organism of origin. Observed (Protein Data Bank entry 1iuqA; 1k30A) and predicted (Psipred) secondary structure elements are coded with letters (H - &#x3B1;-helix, E - &#x3B2;-strand). p.G216 is indicated with an arrow. (DOC 159 kb)</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="10545_2013_9584_MOESM2_ESM.ppt">
            <label>Supplementary Fig. 2</label>
            <caption>
              <p>Densitometry analysis of the data presented in Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>. (PPT 312 kb)</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material id="Fig7" content-type="local-data">
          <media id="MO7" xlink:href="10545_2013_9584_Fig7_ESM.jpg">
            <label>Supplementary Fig. 3</label>
            <caption>
              <p>ECG (patient 1). Sinus rhythm: 120/min. Left axis deviation. Biphasic, flattening T-waves. (JPEG 557 kb)</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="10545_2013_9584_MOESM3_ESM.pdf">
            <label>Supplementary Fig. 4</label>
            <caption>
              <p>ECG (patient 2 at the age of 3 years). Biphasic T waves in I, II, III and left precordial leads, furthermore ECG in normal limits. (PDF 62 kb)</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material id="Fig8" content-type="local-data">
          <media id="MO8" xlink:href="10545_2013_9584_Fig8_ESM.jpg">
            <label>Supplementary Fig. 5</label>
            <caption>
              <p>ECG (Patient 2 at the age of 3 years). Biphasic T waves in I, II, III and left precordial leads, furthermore ECG in normal limits. (JPEG 135 kb)</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material id="Fig9" content-type="local-data">
          <media id="MO9" xlink:href="10545_2013_9584_Fig9_ESM.jpg">
            <label>Supplementary Fig. 6</label>
            <caption>
              <p>ECHO-2D (patient 1). The apical 4-chamber view showing the trabeculations of the left ventricle. The arrows indicate the noncompacted and compacted layers. (JPEG 135 kb)</p>
            </caption>
          </media>
        </supplementary-material>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>Agnieszka Karkucinska-Wieckowska and Joanna Trubicka contributed equally to this work.</p>
      </fn>
    </fn-group>
    <ack>
      <p>This work was supported by the Polish Ministry of Science and Higher Education under the grants NN407 075137 and NN407 118939, the Polish Mitochondrial Network and the Internal Project of The Children&#x2019;s Memorial Health Institute No 117/09, No 119/09 and No 217/12. ML was the recipient of a fellowship from the Foundation for Polish Science (Program Start) and ML and JT an L&#x2019;Oreal fellowship (for women in science).</p>
      <sec id="d30e932">
        <title>Details of funding</title>
        <p>The authors confirm independence from the sponsors; the content of the article has not been influenced by the sponsors.</p>
      </sec>
      <sec id="d30e937">
        <title>Conflict of interest</title>
        <p>None.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arnold</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Pfeiffer</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Yeast mitochondrial F1F0-ATP synthase exist as a dimmer-specific subunits</article-title>
          <source>EMBO J</source>
          <year>1998</year>
          <volume>17</volume>
          <fpage>7170</fpage>
          <lpage>7178</lpage>
          <pub-id pub-id-type="doi">10.1093/emboj/17.24.7170</pub-id>
          <pub-id pub-id-type="pmid">9857174</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Bancroft</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Gamble</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <source>Theory and practice of histological techniques</source>
          <year>2001</year>
          <edition>5</edition>
          <publisher-loc>Edinburgh</publisher-loc>
          <publisher-name>Churchill Livingstone</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barth</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Scholte</surname>
              <given-names>HR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes</article-title>
          <source>J Neurol Sci</source>
          <year>1983</year>
          <volume>62</volume>
          <fpage>327</fpage>
          <lpage>355</lpage>
          <pub-id pub-id-type="doi">10.1016/0022-510X(83)90209-5</pub-id>
          <pub-id pub-id-type="pmid">6142097</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barth</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Valianpour</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update</article-title>
          <source>Am J Med Genet</source>
          <year>2004</year>
          <volume>126A</volume>
          <fpage>349</fpage>
          <lpage>354</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.a.20660</pub-id>
          <pub-id pub-id-type="pmid">15098233</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Besley</surname>
              <given-names>GTN</given-names>
            </name>
            <name>
              <surname>Lendon</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mitochondrial complex deficiencies in a male with cardiomyopathy and 3-methylglutaconic aciduria</article-title>
          <source>J Inherit Metab Dis</source>
          <year>1995</year>
          <volume>18</volume>
          <fpage>221</fpage>
          <lpage>223</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00711772</pub-id>
          <pub-id pub-id-type="pmid">7564252</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bione</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>D&#x2019;Adamo</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel X&#x2013;linked gene, G4.5. is responsible for Barth syndrome</article-title>
          <source>Nature Genet</source>
          <year>1996</year>
          <volume>2</volume>
          <fpage>385</fpage>
          <lpage>389</lpage>
          <pub-id pub-id-type="doi">10.1038/ng0496-385</pub-id>
          <pub-id pub-id-type="pmid">8630491</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brandner</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mick</surname>
              <given-names>DU</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Taz1 an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth syndrome</article-title>
          <source>Mol Biol Cell</source>
          <year>2005</year>
          <volume>16</volume>
          <fpage>5201</fpage>
          <lpage>5214</lpage>
          <pub-id pub-id-type="doi">10.1091/mbc.E05-03-0256</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brown</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>O&#x2019;Rourke</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Cardiac mitochondria and arrhythmias</article-title>
          <source>Cardiovasc Res</source>
          <year>2010</year>
          <volume>88</volume>
          <fpage>241</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="doi">10.1093/cvr/cvq231</pub-id>
          <pub-id pub-id-type="pmid">20621924</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cantlay</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Shokrollabi</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic analysis of the G4.5 gene in families with suspected Barth syndrome</article-title>
          <source>J Pediat</source>
          <year>1999</year>
          <volume>135</volume>
          <fpage>311</fpage>
          <lpage>315</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3476(99)70126-5</pub-id>
          <pub-id pub-id-type="pmid">10484795</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tsuji</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction</article-title>
          <source>Mol Genet Metab</source>
          <year>2002</year>
          <volume>77</volume>
          <fpage>319</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="doi">10.1016/S1096-7192(02)00195-6</pub-id>
          <pub-id pub-id-type="pmid">12468278</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chin</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Perloff</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Wiliams</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Jue</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mohrmann</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Isolated noncompaction of left ventricular myocardium: A study of eight cases</article-title>
          <source>Circulation</source>
          <year>1990</year>
          <volume>82</volume>
          <fpage>507</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.82.2.507</pub-id>
          <pub-id pub-id-type="pmid">2372897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chitayat</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chemke</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>3-methylglutaconic aciduria; a marker for as yet unspecified disorders and the relevance of prenatal diagnosis in a &#x2018;new&#x2019; type (&#x2018;type 4&#x2019;)</article-title>
          <source>J Inherit Metab Dis</source>
          <year>1992</year>
          <volume>15</volume>
          <fpage>204</fpage>
          <lpage>212</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01799632</pub-id>
          <pub-id pub-id-type="pmid">1382150</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Christodoulou</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McInnes</surname>
              <given-names>RR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Barth syndrome; clinical observations and genetic linkage studies</article-title>
          <source>Am J Med Genet</source>
          <year>1994</year>
          <volume>50</volume>
          <fpage>255</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.1320500309</pub-id>
          <pub-id pub-id-type="pmid">8042670</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Claypool</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2009</year>
          <volume>1788</volume>
          <fpage>2059</fpage>
          <lpage>2068</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbamem.2009.04.020</pub-id>
          <pub-id pub-id-type="pmid">19422785</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engberding</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yelbuz</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Breithardt</surname>
            </name>
          </person-group>
          <article-title>Isolated noncompaction of the left ventricular myocardium. A review of the literature two decades after the initial case description</article-title>
          <source>Clin Res Cardiol</source>
          <year>2007</year>
          <volume>96</volume>
          <fpage>481</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="doi">10.1007/s00392-007-0528-6</pub-id>
          <pub-id pub-id-type="pmid">17534568</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Haines TH</collab>
          </person-group>
          <article-title>A new look at cardiolipin</article-title>
          <source>Bioch Biophys Acta</source>
          <year>2009</year>
          <volume>1788</volume>
          <fpage>1997</fpage>
          <lpage>2002</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbamem.2009.09.008</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <mixed-citation publication-type="other">Hanke SP, Gardner AB et al (2012) Left ventricular noncompaction cardiomyopathy in Barth syndrome: An example of an undulating cardiac phenotype necessitating mechanical circulatory support as a bridge to transplantation. Pediatr Cardiol. doi:10.1007/s00246-012-0258-z</mixed-citation>
      </ref>
      <ref id="CR18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Houtkooper</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Rodenburg</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Cardiolipin and monosylocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome</article-title>
          <source>Analyt Biochem</source>
          <year>2009a</year>
          <volume>387</volume>
          <fpage>230</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ab.2009.01.032</pub-id>
          <pub-id pub-id-type="pmid">19454236</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Houtkooper</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Turkenburg</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The enigmatic role of tafazzin in cardiolipin metabolism</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2009b</year>
          <volume>1788</volume>
          <fpage>2003</fpage>
          <lpage>2014</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbamem.2009.07.009</pub-id>
          <pub-id pub-id-type="pmid">19619503</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ischida</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hamamichi</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical features of isolated noncompaction of the ventricular myocardium: long term clinical course, hemodynamic properties, and genetic background</article-title>
          <source>J Am Coll Cardiol</source>
          <year>1990</year>
          <volume>34</volume>
          <fpage>233</fpage>
          <lpage>240</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(99)00170-9</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jenni</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Oechslin</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Echocardiographic and pathoanatomical characteristics of isolated left ventricular noncompaction: a step towards classification as a distinct cardiomyopathy</article-title>
          <source>Heart</source>
          <year>2001</year>
          <volume>86</volume>
          <fpage>666</fpage>
          <lpage>671</lpage>
          <pub-id pub-id-type="doi">10.1136/heart.86.6.666</pub-id>
          <pub-id pub-id-type="pmid">11711464</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnston</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kelley</surname>
              <given-names>RI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation characterization and genotype phenotype correlation in Barth syndrome</article-title>
          <source>Am J Hum Genet</source>
          <year>1997</year>
          <volume>61</volume>
          <fpage>1053</fpage>
          <lpage>1058</lpage>
          <pub-id pub-id-type="doi">10.1086/301604</pub-id>
          <pub-id pub-id-type="pmid">9345098</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karczmarewicz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bielecka</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analytical reliability of spectrophotometric analysis of the activity of mitochondrial respiratory chain complexes in muscle homogenates (in Polish)</article-title>
          <source>Diagn Lab</source>
          <year>1997</year>
          <volume>33</volume>
          <fpage>493</fpage>
          <lpage>503</lpage>
        </element-citation>
      </ref>
      <ref id="CR24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karkucinska-Wieckowska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lebiedzinska</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria)</article-title>
          <source>Folia Neuropathol</source>
          <year>2011</year>
          <volume>49</volume>
          <fpage>56</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">21455844</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelley</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>BJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>X-linked cardiomyopathy, neutropenia, growth retardation, and 3-methylglutaconic aciduria</article-title>
          <source>J Pediat</source>
          <year>1991</year>
          <volume>119</volume>
          <fpage>738</fpage>
          <lpage>745</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3476(05)80289-6</pub-id>
          <pub-id pub-id-type="pmid">1719174</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuijpers</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Maianski</surname>
              <given-names>NA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis</article-title>
          <source>Blood</source>
          <year>2004</year>
          <volume>103</volume>
          <fpage>3915</fpage>
          <lpage>3923</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2003-11-3940</pub-id>
          <pub-id pub-id-type="pmid">14764526</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <mixed-citation publication-type="other">Lamari F, Mochel F et al (2012) Disorders of phospholipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases. J Inherit Metab Dis doi:10.1007/s10545-012-9509-7</mixed-citation>
      </ref>
      <ref id="CR28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lebiedzinska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karkucinska-Wieckowska</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Oxidative stress-dependent p66Shc phosphorylation in skin fibroblasts of children with mitochondrial disorders</article-title>
          <source>Biochim Biophys Acta &#x2013; Bioenergetics</source>
          <year>2010</year>
          <volume>1797</volume>
          <fpage>952</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbabio.2010.03.005</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ostman-Smith</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid</article-title>
          <source>Brit Heart J</source>
          <year>1994</year>
          <volume>73</volume>
          <fpage>349</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="doi">10.1136/hrt.72.4.349</pub-id>
          <pub-id pub-id-type="pmid">7833193</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pronicki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matyja</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Light and electron microscopy characteristics of the muscle of patients with <italic>SURF1</italic> gene mutations associated with Leigh disease</article-title>
          <source>J Clin Pathol</source>
          <year>2008</year>
          <volume>61</volume>
          <fpage>460</fpage>
          <lpage>466</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.2007.051060</pub-id>
          <pub-id pub-id-type="pmid">17908801</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pronicki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kowalski</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A homozygous mutation in the SCO2 gene causes a spinal muscular atrophy like presentation with stridor and respiratory insufficiency</article-title>
          <source>Eur J Paediatr Neurol</source>
          <year>2010</year>
          <volume>14</volume>
          <fpage>253</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejpn.2009.09.008</pub-id>
          <pub-id pub-id-type="pmid">19879173</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saleeb</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Margossian</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reproducibility of echocardiographic diagnosis of left ventricular noncompaction</article-title>
          <source>J Am Soc Echocardiogr</source>
          <year>2012</year>
          <volume>25</volume>
          <fpage>194</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1016/j.echo.2011.10.002</pub-id>
          <pub-id pub-id-type="pmid">22036126</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schagger</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pfeiffer</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Supercomplexes in the respiratory chains in yeast and mammal mitochondria</article-title>
          <source>EMBO J</source>
          <year>2000</year>
          <volume>19</volume>
          <fpage>1777</fpage>
          <lpage>1783</lpage>
          <pub-id pub-id-type="doi">10.1093/emboj/19.8.1777</pub-id>
          <pub-id pub-id-type="pmid">10775262</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Birkebaek</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Barth syndrome without 3-methylglutaconic aciduria</article-title>
          <source>Acta Paediatr</source>
          <year>2004</year>
          <volume>93</volume>
          <fpage>419</fpage>
          <lpage>429</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1651-2227.2004.tb02974.x</pub-id>
          <pub-id pub-id-type="pmid">15124852</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spencer</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Byrne</surname>
              <given-names>BJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ventricular arrhythmia in the X- linked cardiomyopathy Barth syndrome</article-title>
          <source>Pediatr Cardiol</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>632</fpage>
          <lpage>637</lpage>
          <pub-id pub-id-type="doi">10.1007/s00246-005-0873-z</pub-id>
          <pub-id pub-id-type="pmid">16235007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spencer</surname>
              <given-names>CT</given-names>
            </name>
            <name>
              <surname>Bryant</surname>
              <given-names>RM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiac and clinical phenotype in Barth syndrome</article-title>
          <source>Pediatrics</source>
          <year>2006</year>
          <volume>118</volume>
          <fpage>e337</fpage>
          <lpage>e346</lpage>
          <pub-id pub-id-type="doi">10.1542/peds.2005-2667</pub-id>
          <pub-id pub-id-type="pmid">16847078</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sperl</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jesina</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deficiency of mitochondrial synthase of nuclear genetic origin</article-title>
          <source>Neuromuscul Dis</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>821</fpage>
          <lpage>829</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nmd.2006.08.008</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steward</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Newbury-Ecob</surname>
              <given-names>RA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth</article-title>
          <source>Prenat Diagn</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>970</fpage>
          <lpage>976</lpage>
          <pub-id pub-id-type="doi">10.1002/pd.2599</pub-id>
          <pub-id pub-id-type="pmid">20812380</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <mixed-citation publication-type="other">Stollberger C, Gerecke B, Finsterer J, Engberding R (2011) Refinement of echocardiographic criteria for left ventricular noncompaction. Int J Cardiol. doi:10.1016/j.ijcard.2011.08.845</mixed-citation>
      </ref>
      <ref id="CR40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sweeney</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>GJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiomyopathy of unknown etiology: Barth syndrome unrecognized</article-title>
          <source>Congenit Heart Dis</source>
          <year>2008</year>
          <volume>3</volume>
          <fpage>443</fpage>
          <lpage>448</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1747-0803.2008.00226.x</pub-id>
          <pub-id pub-id-type="pmid">19037987</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Coster</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smet</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects</article-title>
          <source>Pediatr Res</source>
          <year>2001</year>
          <volume>50</volume>
          <fpage>658</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="doi">10.1203/00006450-200111000-00020</pub-id>
          <pub-id pub-id-type="pmid">11641463</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vrecken</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Valianpour</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome</article-title>
          <source>Biochim Biophys Res Comun</source>
          <year>2000</year>
          <volume>27</volume>
          <fpage>378</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="doi">10.1006/bbrc.2000.3952</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Werner</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Trubicka</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical and diagnostic aspects of Barth syndrome (X-linked cardiomyopathy)</article-title>
          <source>Kardiologia Polska</source>
          <year>2011</year>
          <volume>69</volume>
          <fpage>1177</fpage>
          <lpage>1180</lpage>
          <pub-id pub-id-type="pmid">22090233</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <mixed-citation publication-type="other">Wortmann SB, Kluijtmans LA et al (2010) The 3-methylglutaconic acidurias: what&#x2019;s new? J Inherit Metab Dis doi:10.1007/s10545-010-9210-7</mixed-citation>
      </ref>
      <ref id="CR45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sutachan</surname>
              <given-names>JJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of lymphoblast mitochondria from patients with Barth syndrome</article-title>
          <source>Lab Invest</source>
          <year>2005</year>
          <volume>85</volume>
          <fpage>823</fpage>
          <lpage>830</lpage>
          <pub-id pub-id-type="doi">10.1038/labinvest.3700274</pub-id>
          <pub-id pub-id-type="pmid">15806137</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
